Literature DB >> 17996488

Aurora kinase small molecule inhibitor destroys mitotic spindle, suppresses cell growth, and induces apoptosis in oral squamous cancer cells.

Caobing Pan1, Min Yan, Jine Yao, Jie Xu, Zijie Long, Hongzhang Huang, Quentin Liu.   

Abstract

Mitotic Aurora kinases are required for accurate chromosome segregation during cell division. Ectopic expression of Aurora-A (Aur-A) kinase results in centrosome amplification, aberrant spindles, and consequent aneuploidy. In the present study, we showed that Aurora kinase inhibitory small molecule VX-680 inhibited histone H3 phosphorylation at Ser10, a known in vivo substrate residue of Aurora kinase, in oral squamous cell carcinoma (OSCC) KB cells. In addition, monopolar spindle structures, typical abnormalities induced by inhibition of Aur-A, were generated in VX-680-treated cells. Inhibition of Aurora kinase led to reduced KB cell growth, as assessed by MTT assay. Western blot analysis revealed that VX-680 caused cleavage of two critical apoptotic associated proteins, PARP and caspase-3. In contrast, expression of cell survival factor Bcl-2 was reduced by VX-680 treatment in a dose-dependent manner. Subsequently, nuclear characteristic of DNA fragmentation, indicative of apoptotic cell death, was clearly observed in these OSCC cells with Aurora kinase inhibitory VX-680. Taken together, we showed that Aurora kinase inhibitory VX-680 led to apoptotic cell death in OSCC cells, suggesting a novel therapeutic target in oral cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996488     DOI: 10.1016/j.oraloncology.2007.08.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  12 in total

1.  Inhibition of Aurora A promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells.

Authors:  Jian-Ming Sun; Li-Na Yang; Han Xu; Bin Chang; Hua-Ying Wang; Gong Yang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  Update on Aurora Kinase Targeted Therapeutics in Oncology.

Authors:  Myke R Green; Joseph E Woolery; Daruka Mahadevan
Journal:  Expert Opin Drug Discov       Date:  2011-03       Impact factor: 6.098

3.  AURKA is a predictor of chemotherapy response and prognosis for patients with advanced oral squamous cell carcinoma.

Authors:  Yadong Li; Jinsong Zhang
Journal:  Tumour Biol       Date:  2014-12-30

4.  Identification and evaluation of novel drug combinations of Aurora kinase inhibitor CCT137690 for enhanced efficacy in oral cancer cells.

Authors:  Muhammad Furqan; Zille Huma; Zainab Ashfaq; Apsra Nasir; Rahim Ullah; Aishah Bilal; Maheen Iqbal; Muhammad Hashaam Khalid; Irshad Hussain; Amir Faisal
Journal:  Cell Cycle       Date:  2019-07-26       Impact factor: 4.534

5.  Aurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancer.

Authors:  Jie Xu; Xing Wu; Wei-hua Zhou; An-wen Liu; Jian-bing Wu; Jin-yun Deng; Cai-feng Yue; Shao-bing Yang; Jing Wang; Zhong-yu Yuan; Quentin Liu
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

6.  Inhibition of mitotic kinase Aurora suppresses Akt-1 activation and induces apoptotic cell death in all-trans retinoid acid-resistant acute promyelocytic leukemia cells.

Authors:  Duo-Rong Xu; Shan Huang; Zi-Jie Long; Jia-Jie Chen; Zheng-Zhi Zou; Juan Li; Dong-Jun Lin; Quentin Liu
Journal:  J Transl Med       Date:  2011-05-21       Impact factor: 5.531

Review 7.  Update on aurora kinase inhibitors in gynecologic malignancies.

Authors:  Xia Tao; Hye S Chon; Siqing Fu; John J Kavanagh; Wei Hu
Journal:  Recent Pat Anticancer Drug Discov       Date:  2008-11       Impact factor: 4.169

8.  EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.

Authors:  Hem Chandra Jha; Jie Lu; Abhik Saha; Qiliang Cai; Shuvomoy Banerjee; Mahadesh A J Prasad; Erle S Robertson
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

9.  Plk2 regulates mitotic spindle orientation and mammary gland development.

Authors:  Elizabeth Villegas; Elena B Kabotyanski; Amy N Shore; Chad J Creighton; Thomas F Westbrook; Jeffrey M Rosen
Journal:  Development       Date:  2014-03-05       Impact factor: 6.868

10.  Aurora-A down-regulates IkappaBalpha via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival.

Authors:  Jin-E Yao; Min Yan; Zhong Guan; Chao-Bin Pan; Liang-Ping Xia; Chuan-Xing Li; Li-Hui Wang; Zi-Jie Long; Yan Zhao; Ming-Wei Li; Fei-Meng Zheng; Jie Xu; Dong-Jun Lin; Quentin Liu
Journal:  Mol Cancer       Date:  2009-11-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.